NEW
YORK, Oct. 4, 2023 /PRNewswire/ -- Shareholder
rights law firm Julie & Holleman LLP is investigating potential
breaches of fiduciary duty relating to the proposed merger between
Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic, Inc. (Nasdaq:
SLGC).
For a no-cost consult and to learn more about our investigation,
please click here or visit:
https://julieholleman.com/?p=3147
Standard BioTools, previously known as Fluidigm Corporation, is
a company that develops, manufactures, and sells technologies that
help biomedical researchers develop medicines faster and better.
SomaLogic is a leading commercial-stage proteomics company.
On October 4, 2023, Standard
BioTools and SomaLogic announced a merger whereby Standard BioTools
will issue new shares of stock to existing SomaLogic shareholders.
After the merger, which is expected to close in early 2024, current
Standard BioTools shareholders will own 43% of the combined
company, with SomaLogic's current shareholders owning the remaining
57%.
Julie & Holleman, a nationally recognized shareholder rights
firm, is investigating potential breaches of fiduciary duty and has
already identified several areas of concern.
If you would like more information about Julie & Holleman's
investigation, or about the acquisition in general, please contact
W. Scott Holleman by email at
scott@julieholleman.com or by telephone at (929) 415-1020. You may
also visit the firm's website by clicking here.
About the Firm
Julie & Holleman is a boutique law firm that focuses on
shareholder litigation, including derivative actions, mergers and
acquisitions cases, securities fraud class actions,
and corporate investigations. The firm's attorneys litigate in
state and federal courts across the nation and have helped secure
hundreds of millions of dollars for aggrieved companies and their
shareholders. For more information about the firm, please visit
https://www.julieholleman.com/. This notice may constitute attorney
advertising.
CONTACT INFORMATION
Julie & Holleman LLP
W. Scott Holleman, Esq.
157 East 86th Street
4th Floor
New York, NY 10028
(929) 415-1020
www.julieholleman.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lab-investor-alert-julie--holleman-llp-announces-investigation-of-proposed-merger-between-standard-biotools-and-somalogic-301947275.html
SOURCE Julie & Holleman LLP